SIDMAP Launches a Metabolomics Service for Early Detection of Drug-Induced Liver and Kidney Toxicity.
LOS ANGELES--(BUSINESS WIRE)--SiDMAP, LLC, announced that it has expanded its SiDTox™ services to enable rapid and specific detection of drug-induced organ toxicity. Using its proprietary metabolomics technology platform, SiDMAP is able to monitor changes in vital metabolite fluxes in response to drug treatment to quickly determine organ toxicity before structural or morphological damage occurs.